News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Articles|October 2, 2017

Take the CURE Magazine Survey

Author(s)Staff

Thank you for answering the questions below.

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Dr. Francesca Palandri

Anemia Management in Myelofibrosis: Survival and Quality of Life

ByRyan Scott
October 25th 2025
Maureen McBeth

Simple Ways for Patients With Cancer to Start Exercising

ByAlex Biese
October 25th 2025
Georgia Hurst

Finding Credible Voices in the Lynch Syndrome Community

ByGeorgia Hurst
October 24th 2025
Image of lymphoma.

Understanding Your Stage 2 Lymphoma Diagnosis

ByRyan Scott
October 24th 2025
FDA Approval logo

FDA Approves Revuforj for R/R NPM1-Mutant AML

ByAlex Biese
October 24th 2025
Advertisement
Advertisement

Trending on CURE

1

Simple Ways for Patients With Cancer to Start Exercising

2

FDA Fast Tracks MT-125 for Glioblastoma

3

Finding Credible Voices in the Lynch Syndrome Community

4

How Does FDA-Approved Blenrep Treat Multiple Myeloma?

5

FDA Approves Revuforj for R/R NPM1-Mutant AML

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.